title: Relationship between erythropoietin administration and the endothelial nitric oxide synthase gene polymorphism in patients with hemodialysis.
authors.forename: K
authors.initials: K
authors.lastname: Yokoyama
authors.forename: T
authors.initials: T
authors.lastname: Tsukada
authors.forename: Y
authors.initials: Y
authors.lastname: Matushita
authors.forename: M
authors.initials: M
authors.lastname: Yokota
authors.forename: F
authors.initials: F
authors.lastname: Takemoto
authors.forename: S
authors.initials: S
authors.lastname: Hara
authors.forename: A
authors.initials: A
authors.lastname: Yamada
authors.forename: Y
authors.initials: Y
authors.lastname: Kawaguchi
authors.forename: T
authors.initials: T
authors.lastname: Hosoya
mesh_terms: D000483:Alleles; D000740:Anemia / Q000209:etiology / Q000517:prevention & control; D004921:Erythropoietin / Q000008:administration & dosage*; D005260:Female; D005787:Gene Frequency; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000201:enzymology* / Q000235:genetics; D008297:Male; D008875:Middle Aged; D019001:Nitric Oxide Synthase / Q000235:genetics*; D052250:Nitric Oxide Synthase Type III; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic; D006435:Renal Dialysis
chemical_list: D004921:Erythropoietin; C496314:NOS3 protein, human; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III